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444a Tuesday, February 5, 2013Using an animal model knocked in for the RYR1Y522S mutation we observed
that bleeding times were increased by more than two fold in heterozygous
mice compared to their wild type littermates, with no differences in platelet
numbers nor aggregation characteristics between heterozygous RYR1Y522S car-
riers and control littermates. Bleeding abnormalities have also been seen in
some patients with dominant RYR1mutations; as part of a comprehensive study
we investigated in detail RyR1 expression in smooth muscle cells isolated from
different tissues and if there is a causal link between RYR1 mutations and pro-
longed bleeding times.
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Ryanodine receptors (RyRs) form a class of intracellular calcium release chan-
nels in various excitable tissues and cells such as muscles and neurons. They are
themajor cellularmediators of the release of calcium ions from the sarcoplasmic
reticulum, an essential step in muscle excitation-contraction coupling. Several
crystal structures of skeletal muscle RyR1 peptide fragments have been solved,
but these cover less than 15% of the full-length RyR1 sequence. In the present
study, we obtain pseudo-atomic models for RyR fragments, consisting of resi-
dues 850-1,056 in rabbit RyR1 or residues 861-1,067 in mouse RyR2, by com-
bining modeling techniques with sub-nanometer resolution cryo-electron
microscopy (cryo-EM)maps. These fragments dock into a domain that connects
the central vestibule and corner clamp region of RyR, with a good match be-
tween the secondary structure elements in the cryo-EM map and the pseudo-
atomic models, and also consistent with our previous results of 3D cryo-EM
RyR-GFP mapping and FRET measurement between RyR and FKBP. A com-
bined model of the RyR fragment and FKBP docked into the cryo-EM map
suggests that the fragment is positioned adjacent to the FKBP binding site. Its
predicted binding interface with FKBP consists of primarily electrostatic con-
tacts and contains several disease-associated mutations. A dynamic interaction
between the fragment and a RyR phosphorylation domain, characterized using
FRET data, also support the structural predictions of the pseudo-atomic models.
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Ryanodine receptors (RyRs) are large Ca2þ-release channels located in the SR
membrane. They play a central role in the excitation-contraction coupling of
skeletal (RyR1) and cardiac (RyR2) muscle. Over 500 disease mutations
have been identified in RyRs that can cause several skeletal muscle disorders
and cardiac arrhythmias. RyRs are also the target for phosphorylation, most
notably by CaMKII and PKA. Although a lot of controversy surrounds these
events, several studies indicate that phosphorylation can upregulate RyR
activity. Here we present crystal structures of a domain in all three different
RyR isoforms, containing the Ser2843 (RyR1) and Ser2808/Ser2814 (RyR2)
phosphorylation sites. There are 11 disease mutations located in the RyR1
domain, several of which cluster near the phosphorylation site, suggesting
that phosphorylation and disease mutations may affect the same interface.
Crystal structures of the disease mutants show that the mutations affect either
surface properties or intradomain salt bridges. One mutation, L2867G, causes
a drastic reduction of thermal stability of the domain, and results in aggregation
at room temperature. In vitro phosphorylation experiments identify several
novel PKA and CaMKII phosphorylation sites in the same loop region of the
RyR2 phosphorylation domain, also supported by another recent in vivo study.
The observation of simultaneous phosphorylation events on multiple sites
indicates that RyRs may be truly ‘hyperphosphorylated’. Docking into cryo-
electron microscopy maps locates the domain in the clamp region, a region
that has been shown to couple allosterically to channel opening. Disease muta-
tions and phosphorylation may therefore cause conformational changes that
affect the allosteric coupling and facilitate channel opening.
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Go¨ttingen, Germany.In super-resolution microscopy applications, previously unknown fluorescent
signal patterns are recorded. The interpretation of such nanoscale data is often
unexpectedly complex, and can be performed by different analysis strategies:
1) empirical statistics of the spatial distribution of intensity values to identify
local objects, 2) inverse problem approaches to convert signals into objects
based on external data models or other external assumptions, 3) decomposition
of spatial signal patterns into spatial modes.
Here, we compare and relate two distinct approaches of analysing STED
microscopy images of RyR2 clusters (cardiac ryanodine receptor type 2).
RyR2 Ca2þ release channels are essential for heart muscle function (excita-
tion-contraction coupling). Yet, the nature of lateral channel organization
within super-structural clusters is unknown and important for models of local
control mechanisms of RyR2 Ca2þ release activity.
We established multi-scale analysis of RyR2 signal patterns employing wavelet
analysis. This analysis decomposes the initial image with predefined wavelets
into spatial modes identifying dominant scales of signal fluctuations. We tested
the sensitivity of this approach for different wavelets with artificial and modi-
fied images. Distinct scales represent inter-cluster spacing and intra-cluster
patterns, respectively. Furthermore, we compare the spatial mode analysis
with object-based approaches. For object-based analysis, RyR2 cluster sub-
structures were identified with a multi-step thresholding procedure. After
increasing the threshold level step-by-step, the hierarchy of the segmentation
output was analysed with logical operators. Accordingly, we identified cluster
sub-structures as discrete objects of variable sizes with typical spacings ranging
from 78 to 128 nm (IQR range) that we interpret as individual cluster building-
blocks.
We conclude that identification of common protein cluster building principles
in highly variable signal structures as typical for RyR2 clusters benefits from
combining object-based approaches with spatial mode analysis.
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Many potassium channels use a conserved glycine residue to allow flexibility of
the inner helices and facilitate gating. A KcsA-based analogy model of the
RyR2 pore-forming region (Welch et al Biophys J 87: 2335-2351) indicates
that this region is composed of structural elements equivalent to those found
in potassium channels and includes a potentially equivalent inner-helix hinge
motif (GXXXXA).
We studied the functional consequences of substitutions of the conserved gly-
cine residue at position 4864 in recombinantly expressed human RyR2 GFP-
tagged proteins. Whilst wild type (WT) RyR2 and the mutants G4864A and
G4864V were expressed at equivalent levels in HEK293 cells, G4864P was
less tolerated with a reduced expression. This was confirmed by western blot
analysis in HEK293 membrane preparations.
Caffeine-induced intracellular calcium release was observed in Fluo3-loaded
HEK293 cells expressing WT, G4864A and G4864P RyR2 channels. In con-
trast cells expressing G4864V were not sensitive to caffeine. [3H]-ryanodine
binding to HEK293 membrane preparations resulted in similar specific binding
for WT and G4864A at 0.192 5 0.005 and 0.190 5 0.002 pmol/mg, while
G4864V and G4864P showed comparable low values of 0.006 5 0.001 and
0.002 5 0.002 pmol/mg, respectively. Characteristic single channel current
fluctuations were observed following the incorporation of purified WT and
G4864A RyR2 proteins into planar phospholipid bilayers and G4864A
channels displayed ion handling, and calcium-dependent gating properties
comparable to WT channels. No equivalent activity was observed for
G4864V and G4864P.
Our investigation indicates that whilst functionally sensitive to mutagenesis,
a glycine residue at 4864 is not essential for RyR2 channel gating. Rather, there
is a requirement for amino acids with small side chains that allow close packing
of helices during transitions from closed to open states. The BHF supported this
research.
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The ryanodine receptor (RyR) and dihydropyridine receptor (DHPR) along
with several other smaller proteins form a large and dynamic complex, often
referred to as the excitation-contraction coupling machinery. Complexes of
Tuesday, February 5, 2013 445aRyR1 and its protein ligands are often not stable in vitro and therefore difficult
to study by single-particle cryo-electron microscopy (cryo-EM). The main goal
of this study was to develop a procedure to cross-link protein ligands to RyR1
and visualize these complexes by single-particle cryo-EM. To test the cross-
linking protocol we used the complex of FK506-binding protein and RyR1
(FKBP12:RyR1) as a model system, since the structure of FKBP12:RyR1 is
known. Glutaraldehyde quantitatively cross-linked RyR1 subunits to each other
and FKBP12 to RyR1 without damaging the ultrastructure. Cross-linked
FKBP12:RyR1 was visualized in 2D averages, and was identical to that of pre-
viously published non-cross-linked FKBP12:RyR1. The effect of glutaralde-
hyde cross-linking on RyR1 structure was characterized using 3D single-
particle cryo-EM and by [3H]ryanodine binding assay. Glutaraldehyde cross-
linking preserved the gross morphology of RyR1, but induced minor structural
changes at the cytoplasmic and transmembrane regions of RyR1. Glutaralde-
hyde cross-linking enhanced [3H]ryanodine binding to RyR1 by ~30%. Based
on these results we propose that cross-linking RyR1 subunits by glutaraldehyde
locked RyR1 in an open-like conformation state.
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The type 1 ryanodine receptor (RyR1) is an intracellular Ca2þ release channel
that mediates skeletal muscle excitation contraction coupling. While the over-
all shape of RyR1 has been elucidated using cryo electron microscopic recon-
structions, fine structural details remain elusive. To better understand the
structure of RyR1, we have previously used a fluorescence resonance energy
transfer (FRET)-based method using a fused green fluorescent protein (GFP)
donor and a fluorescent acceptor, Cy3NTA that binds specifically to short
poly-histidine ‘tags’ engineered into RyR1. However, the large size of the
GFP fusions and the need to permeabilize cells expressing these constructs
(to allow Cy3NTA entry) limits interpretation of the resulting FRET data.
To overcome these problems, we used a dodecapeptide sequence containing
a tetracysteine (Tc) motif to target the bi-arsenical fluorophores, FlAsH and
ReAsH to RyR1. These compounds freely cross intact cell membranes where
they then bind covalently to the tetracysteine motif. First, we used this system
to conduct FRET measurements in intact cells by fusing a YFP FRET donor
to the N-terminus of RyR1 and then targeting the FRET acceptor, ReAsH to
an adjacent Tc tag. High levels of energy transfer (~50%) were observed
whereas incubation of ReAsH with a YFP-RyR1 fusion protein lacking the
Tc tag resulted in no detectable FRET. We also developed a FRET-based
system that did not require GFP fusions into RyR1 by labeling N-terminal
Tc-tagged RyR1 with FlAsH, a FRET donor and then targeting the FRET
acceptor Cy3NTA to an adjacent His tag. A high degree of energy transfer
(~70%) indicated proper binding of both compounds to these unique recogni-
tion sequences in RyR1. Thus, these two systems provide unprecedented flex-
ibility in FRET-based structural determinations of RyR1. Supported by NIH
grant R01AR059124.
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We used fluorescence resonance energy transfer (FRET) to localize three
divergent region domains within the type 1 ryanodine receptor (RyR1), an in-
tracellular Ca2þ channel that mediates skeletal muscle excitation-contraction
(EC) coupling. Initial cloning studies of the three RyR isoforms identified
three ‘‘divergent regions’’ of primary sequence dissimilarity spanning amino
acids 4254-4631 (DR1), 1342-1403 (DR2) and 1872-1923 (DR3) in RyR1.
These regions have been implicated in EC coupling as well as in differential
sensitivity to pharmacological agonists. Here, we used permeabilized HEK-
293T cells expressing recombinant RyR1 to localize these DRs to the cryo
electron microscopic (EM) map of RyR1. First, we measured FRET from
a green fluorescent protein (GFP) donor fused to either position 1 or 620 of
RyR1, to a FRET acceptor, Cy3NTA, targeted to poly-histidine ‘‘tags’’ in-
serted into DR1 (at position 4429), DR2 (at position1358) or DR3 (at position
1915). While FRET was not detected for His-tagged constructs containing
GFP fused at position 1, FRET was observed from GFP fused at position
620 to all 3 His-tagged positions. Second, we targeted a donor to the RyR1
cytoplasmic domain using FKBP12.6 labeled with Alexa Fluor 488, and
then measured FRET to Cy3NTA targeted to the His tag sites describedabove. Donor-FKBPs bound with high-affinity to both recombinant wild
type and His-tagged RyRs. FRET was detected from donor conjugated to
each of four, well-separated positions on FKBP to Cy3NTA targeted to
each divergent region. Since the fused GFPs and FKBP12.6 have already
been localized within the cryo EM map of RyR1, we can now triangulate
the DR positions to the cryo EM map from these two complementary data
sets. Supported by NIH grant R01AR059124 (to JDF, MM, and TG) and
R01HL092097 (to RLC).
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The skeletal muscle Ryanodine Receptor (RyR1) is a large calcium release
channel involved in excitation-contraction coupling. It is also the target for
hundreds of disease mutations that cause malignant hyperthermia (MH) or
skeletal muscle disorders like central core disease (CCD). MH is typically
triggered by volatile anesthetics, but their binding site on RyR1 has not
been fully described. RyR1 is under the control of several auxiliary proteins.
One of these is Calmodulin (CaM), a Ca2þ-binding protein that can suppress
RyR1 activity at elevated Ca2þ concentrations. Here we investigate how
CaM can bind to RyR1, and how this may be affected by volatile anesthetics.
We found that CaM can bind to at least three different RyR1 peptides, with
the affinity and lobe specificity being altered substantially by the Ca2þ
concentrations. In addition, we identified two binding sites for sevoflurane,
a volatile anesthetic, on Ca2þ/CaM. The anesthetic binds to a pocket that is
involved in binding RyR1 peptides. In addition, it can alter the affinity of
the N-terminal CaM lobe for Ca2þ. These findings suggest that binding of
anesthetics to CaM may be involved in the pathophysiology of malignant
hyperthermia.
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In skeletal muscle, RyR1 (5,037 residues) forms a homo-tetrameric Ca2þ-re-
lease channel in the sarcoplasmic reticulum (SR), mediates excitation-
contraction coupling in response to an orthograde signal from the DHPR in
the plasma membrane, and retrogradely enhances L-type Ca2þ current via
the DHPR. The RyR1 C-terminus forms the Ca2þ channel pore across the
SR membrane and is believed to be important for inter-subunit interactions,
whereas the bulk (~85%) of the protein (the so-called foot) bridges the junc-
tional, myoplasmic gap between the SR and plasma membranes. Here, we
have examined the ability of the foot domain (residues 1-4300; RyR11:4300)
to target junctionally and interact with the DHPR by expression of a cDNA en-
coding YFP-RyR11:4300. In dysgenic (a1S-null) myotubes which lack DHPRs,
YFP-RyR11:4300 was diffusely distributed and, on the basis of photobleaching,
freely mobile within the cytoplasm, consistent with the loss of membrane an-
choring. However, after expression in dyspedic (RyR1 null) myotubes (which
have DHPRs), much of YFP-RyR11:4300 was immobile within fluorescent foci
near the myotube surface, suggestive of junctional targeting and binding to
DHPRs. Junctional targeting was confirmed by partial co-localization of
YFP-RyR11:4300 and CFP-labeled a1S after co-expression in dyspedic myo-
tubes. Strikingly, YFP-RyR11:4300 was able to retrogradely enhance peak
Ca2þ current in dyspedic myotubes from 1.6 pA/pF (control) to 6.7 pA/pF, sim-
ilar to that after expression of full-length RyR1 (7.4 pA/pF). Thus, the isolated,
cytoplasmic foot of RyR1 retains the ability to target junctionally and to inter-
act functionally with the DHPR.
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In skeletal muscle, the dihydropyridine receptor (DHPR) in the plasma mem-
brane engages in bi-directional interactions with the type 1 ryanodine receptor
(RyR1) in the sarcoplasmic reticulum (SR) such that an ‘‘orthograde’’ signal
from the DHPR triggers SR Ca2þ release via RyR1, and a retrograde signal
